Regal Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$813K Buy
5,322
+272
+5% +$41.7K 0.05% 332
2025
Q4
$696K Buy
+5,050
New +$661K 0.04% 355
2022
Q3
Sell
-2,400
Closed -$203K 517
2022
Q2
$203K Buy
2,400
+64
+3% +$5.62K 0.02% 459
2022
Q1
$205K Buy
+2,336
New +$202K 0.02% 503
2021
Q4
Sell
-2,837
Closed -$232K 551
2021
Q3
$232K Buy
2,837
+413
+17% +$37.2K 0.02% 475
2021
Q2
$221K Buy
+2,424
New +$216K 0.02% 495
2021
Q1
Sell
-2,663
Closed -$251K 297
2020
Q4
$251K Buy
+2,663
New +$233K 0.03% 398
2020
Q3
Sell
-3,410
Closed -$298K 185
2020
Q2
$298K Buy
+3,410
New +$294K 0.05% 243
2018
Q2
Sell
-3,816
Closed -$276K 298
2018
Q1
$276K Buy
3,816
+119
+3% +$9.06K 0.06% 241
2017
Q4
$278K Buy
3,697
+353
+11% +$26.6K 0.06% 232
2017
Q3
$257K Buy
+3,344
New +$253K 0.06% 232
2016
Q1
Sell
-3,296
Closed -$254K 278
2015
Q4
$254K Buy
3,296
+23
+0.7% +$1.83K 0.07% 221
2015
Q3
$269K Sell
3,273
-95
-3% -$8.46K 0.07% 200
2015
Q2
$296K Sell
3,368
-188
-5% -$17.2K 0.08% 187
2015
Q1
$314K Buy
3,556
+1,016
+40% +$90.1K 0.08% 194
2014
Q4
$211K Buy
2,540
+578
+29% +$47.9K 0.06% 220
2014
Q3
$165K Buy
1,962
+1,312
+202% +$106K 0.05% 240
2014
Q2
$53K Buy
+650
New +$51.1K 0.02% 377

Other funds holding NVS

Regal Investment Advisors's NVS Position: Q1 2026 in Review

Regal Investment Advisors increased its Novartis (NVS) stake by 5.4% in Q1 2026, buying an estimated $41.7K and bringing the position to 5,322 shares worth $813K. The position accounts for 0.05% of the portfolio, ranked #332.

Regal Investment Advisors first reported a position in NVS in Q2 2014 and has held it in 18 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Regal Investment Advisors held 5,322 shares of Novartis worth $813K as of Q1 2026.
  • Regal Investment Advisors bought 272 Novartis shares in Q1 2026, an estimated $41.7K.
  • Novartis made up 0.05% of Regal Investment Advisors's portfolio in Q1 2026, its #332 holding.
  • Regal Investment Advisors first reported a position in Novartis in Q2 2014 and has held it in 18 quarters since.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.